US › Healthcare

Intelligent Bio Solutions Inc. (INBS)

US · Healthcare · Medical Devices

$1.81-0.55%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.1M
Revenue YoY
+45.5%
Net profit
$-2.9M
Profit YoY
-12.5%
EPS
$-1.80
EPS estimate
$1.40
Net margin
-269.9%

EPS came in at -1.80 against a street estimate of 1.40 — a miss of 228.6%.

Key statistics

Market cap
$4.4M
Forward P/E
0.0
P/B
0.48
Book value
$4.48
EPS (TTM)
$-11.62
52-week high
$24.90
52-week low
$1.52
50-day MA
$2.23
200-day MA
$5.25
Beta
4.21

Analyst view

Analysts rate Intelligent Bio Solutions Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.00.

Shareholding

Insiders
3.57%
Institutions
8.71%

Largest institutional holders

FundStake
Armistice Capital, LLC5.44%
Alyeska Investment Group, L.P.1.59%
Geode Capital Management, LLC1.20%
Vanguard Capital Management, LLC0.24%
Vanguard Fiduciary Trust Co0.17%
Tower Research Capital LLC0.05%
UBS Group AG0.02%
CURIO WEALTH, LLC0.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Intelligent Bio Solutions Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.